InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by DeLuca Richard R., Chief Executive Officer. Officer active across 1 companies, notably Merck & Co., Inc.. Cumulatively, 5 filings have been recorded. The latest transaction was filed on 24 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
€1m15,966 shares@ €65.02030.0004% mcap100.0% of flow
Common Stock
SEC:0001127602-22-007002:0·
029,782 shares0
Common Stock
SEC:0001127602-21-028469·
029,782 shares0
Common Stock
SEC:0001127602-21-028469:0·
073,026 shares0
Common Stock
SEC:0001127602-21-028165·
073,026 shares0
Common Stock
SEC:0001127602-21-028165:0·
5 of 5 declarations
About DeLuca Richard R.
Richard R. DeLuca is the Executive Vice President and President of Merck Animal Health, a division of Merck & Co., Inc. He oversees the operations of this division, defining growth and innovation strategies. His leadership is essential for ensuring the success of Merck Animal Health.
